Comparative bioavailability of clarithromycin formulations in healthy brazilian volunteers

Comparative bioavailability of clarithromycin formulations in healthy brazilian volunteers

A. P. D. Ruenis, R. A. Moreno, E. B. Abib-Júnior, R. P. Simões, L. M. Franco, F. C. Groppo, S. Baglie, G. C. N. Franco, P. L. Rosalen

ARTIGO

Inglês

To compare the bioavailability of clarithromycin 500 mg tablets (Merck S.A Industrias Quinnicas, Sao Paulo, SP, Brazil, used as test formulation) and Klaricid(R) (Abbott Laboratorios do Brasil Ltda, Sao Paulo, SP, Brazil, used as reference formulation) in 24 healthy Volunteers. The study was...

CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ

fechado

Comparative bioavailability of clarithromycin formulations in healthy brazilian volunteers

A. P. D. Ruenis, R. A. Moreno, E. B. Abib-Júnior, R. P. Simões, L. M. Franco, F. C. Groppo, S. Baglie, G. C. N. Franco, P. L. Rosalen


										

Comparative bioavailability of clarithromycin formulations in healthy brazilian volunteers

A. P. D. Ruenis, R. A. Moreno, E. B. Abib-Júnior, R. P. Simões, L. M. Franco, F. C. Groppo, S. Baglie, G. C. N. Franco, P. L. Rosalen

    Fontes

    International journal of clinical pharmacology and therapeutics

    Vol. 43, no. 8 (Aug., 2005), p. 399-404